Brought to you by 
Roche buys Boehringer Mannheim and DePuy from Corange
10 Sep 2012
Executive Summary
Pharmaceutical giant Roche has agreed to purchase all the shares of Corange for about $11bn, thus gaining the holding company's drug and diagnostics group Boehringer Mannheim as well as its majority stake in the US orthopedics company DePuy.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Medical Devices
- Implantable Devices
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Roche buys Boehringer Mannheim and DePuy from Corange
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice